143 related articles for article (PubMed ID: 38458435)
1. Pharmacoequity and Biologics in the Allergy Clinic: Providing the Right Care, at the Right Time, Every Time, to Everyone.
Conway AE; Lieberman J; Codispoti CD; Mahdavinia M; Anagnostou A; Hsu Blatman KS; Lang DM; Oppenheimer J; Mosnaim GS; Bukstein D; Shaker M
J Allergy Clin Immunol Pract; 2024 May; 12(5):1170-1180. PubMed ID: 38458435
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoequity in Allergy-Immunology: Disparities in Access to Medications for Allergic Diseases and Proposed Solutions in the United States and Globally.
Maldonado-Puebla M; Akenroye A; Busby J; Cardet JC; Louisias M
J Allergy Clin Immunol Pract; 2024 Feb; 12(2):272-280. PubMed ID: 37951413
[TBL] [Abstract][Full Text] [Related]
3. Pursuing Pharmacoequity: Determinants, Drivers, and Pathways to Progress.
Chalasani R; Krishnamurthy S; Suda KJ; Newman TV; Delaney SW; Essien UR
J Health Polit Policy Law; 2022 Dec; 47(6):709-729. PubMed ID: 35867522
[TBL] [Abstract][Full Text] [Related]
4. The growing role of biologics and biosimilars in the United States: Perspectives from the APhA Biologics and Biosimilars Stakeholder Conference.
Crespi-Lofton J; Skelton JB
J Am Pharm Assoc (2003); 2017; 57(5):e15-e27. PubMed ID: 28689708
[TBL] [Abstract][Full Text] [Related]
5. Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity.
Amin K; Bethel G; Jackson LR; Essien UR; Sloan CE
Curr Atheroscler Rep; 2023 Dec; 25(12):1113-1127. PubMed ID: 38108997
[TBL] [Abstract][Full Text] [Related]
6. Strategies for choosing a biologic for your patient with allergy or asthma.
Saco T; Ugalde IC; Cardet JC; Casale TB
Ann Allergy Asthma Immunol; 2021 Dec; 127(6):627-637. PubMed ID: 34642091
[TBL] [Abstract][Full Text] [Related]
7. Future of biologics in pediatric asthma: Optimizing response, early introduction, and equitable access to treatment.
Schepel IRM; Banzon TM; Phipatanakul W
Ann Allergy Asthma Immunol; 2024 Jan; 132(1):13-20. PubMed ID: 37652232
[TBL] [Abstract][Full Text] [Related]
8. Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists.
Raine T; Gkini MA; Irving PM; Kaul A; Korendowych E; Laws P; Foulkes AC
BioDrugs; 2021 Mar; 35(2):187-199. PubMed ID: 33635522
[TBL] [Abstract][Full Text] [Related]
9. Factors Related to Biologic Adherence and Outcomes Among Moderate-to-Severe Asthma Patients.
Osazuwa-Peters OL; Greiner MA; Oberle A; Oakes M; Thomas SM; Bosworth H
J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2355-2366. PubMed ID: 35640790
[TBL] [Abstract][Full Text] [Related]
10. Social, political, and economic determinants of access to biologics: A scoping review of structural determinants in the clinical disparities literature.
Sariahmed K; Kurian J; Singh AK; Leyton C; Minuti A; Jerschow E; Arora S; Jariwala SP
Res Social Adm Pharm; 2022 Dec; 18(12):4038-4047. PubMed ID: 35963767
[TBL] [Abstract][Full Text] [Related]
11. Biologics for asthma and allergy.
Walsh GM
Curr Opin Otolaryngol Head Neck Surg; 2017 Jun; 25(3):231-234. PubMed ID: 28234780
[TBL] [Abstract][Full Text] [Related]
12. Equity in health care access to: assessing the urban health insurance reform in China.
Liu GG; Zhao Z; Cai R; Yamada T; Yamada T
Soc Sci Med; 2002 Nov; 55(10):1779-94. PubMed ID: 12383462
[TBL] [Abstract][Full Text] [Related]
13. Addressing Health Equity in Food Allergy.
Dehbozorgi S; Ramsey N; Lee ASE; Coleman A; Varshney P; Davis CM
J Allergy Clin Immunol Pract; 2024 Mar; 12(3):570-577. PubMed ID: 38280451
[TBL] [Abstract][Full Text] [Related]
14. Health disparities in pediatric food allergy.
Tepler E; Wong KH; Soffer GK
Ann Allergy Asthma Immunol; 2022 Oct; 129(4):417-423. PubMed ID: 35476967
[TBL] [Abstract][Full Text] [Related]
15. Patient's access to healthcare and treatment in rheumatoid arthritis: the views of stakeholders in Portugal.
Laires PA; Mesquita R; Veloso L; Martins AP; Cernadas R; Fonseca JE
BMC Musculoskelet Disord; 2013 Sep; 14():279. PubMed ID: 24067096
[TBL] [Abstract][Full Text] [Related]
16. Biologic logistics: Connecting with patients taking biologics.
Darveaux J
Ann Allergy Asthma Immunol; 2020 Apr; 124(4):309-310. PubMed ID: 32006705
[No Abstract] [Full Text] [Related]
17. The effects of MCH insurance cards on improving equity in access and use of maternal and child health care services in Tanzania: a mixed methods analysis.
Kuwawenaruwa A; Mtei G; Baraka J; Tani K
J Health Popul Nutr; 2016 Nov; 35(1):37. PubMed ID: 27863508
[TBL] [Abstract][Full Text] [Related]
18. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
20. [Off-label use of biologics for rare immunological disorders].
Musters A; Assaf A; Baeten DL; Tas SW
Ned Tijdschr Geneeskd; 2013; 157(49):A6419. PubMed ID: 24299626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
